Related Experiment Video

Updated: May 27, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

State of art and recent developments of anti-cancer strategies based on TRAIL

Stella Bernardi1, Paola Secchiero, Giorgio Zauli

  • 1Department of Morphology and Embryology and LTTA Centre, University of Ferrara, Ferrara, Italy.

Recent Patents on Anti-Cancer Drug Discovery
|November 26, 2011
PubMed

Insights

Apoptosis, or programmed cell death, is a natural anti-cancer mechanism. Targeting this process, particularly the TRAIL pathway, shows promise as a safe and effective cancer therapy strategy.

Area of Science:

  • Oncology
  • Cell Biology

Background:

  • Apoptosis is crucial for eliminating damaged cells and acts as a natural anti-cancer mechanism.
  • Defects in apoptosis are observed in over 50% of human cancers, highlighting its importance in cancer development.
  • Understanding apoptosis has led to novel anti-cancer therapeutic strategies.

Purpose of the Study:

  • To review recent advancements and patents concerning TRAIL (TNF-related apoptosis-inducing ligand) or TRAIL mimetics.
  • To explore combination therapies involving TRAIL-based strategies for cancer treatment.

Main Methods:

  • Review of preclinical and clinical studies on targeting the extrinsic apoptotic pathway.
  • Analysis of recent scientific literature and patent filings related to TRAIL and its agonists.
  • Evaluation of combination therapy approaches.

Main Results:

  • Targeting the extrinsic apoptotic pathway via death receptor agonists is a safe and effective anti-cancer strategy.
  • TRAIL and TRAIL mimetics represent a promising therapeutic avenue.
  • Combination therapies may enhance the efficacy of TRAIL-based treatments.

Conclusions:

  • Targeting the extrinsic apoptotic pathway is a viable and safe anti-cancer strategy.
  • TRAIL agonists and mimetics are emerging as a new cornerstone in cancer therapy.
  • Further research into combination therapies is warranted to optimize treatment outcomes.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...